Literature DB >> 19282368

High milk consumers have an increased risk of folate receptor blocking autoantibody production but this does not affect folate status in Spanish men and women.

Maria Isabel Berrocal-Zaragoza1, Michelle M Murphy, Santiago Ceruelo, Edward V Quadros, Jeffrey M Sequeira, Joan D Fernandez-Ballart.   

Abstract

Folate receptor (FR)-blocking autoantibodies (FR-autoantibodies) have been reported in women with neural tube defect-affected pregnancies and subfertility and in children with progressive neurodevelopment disorders. We investigated their prevalence and association with folate status and milk intake in adults unexposed to folic acid fortification. A cross-sectional study of a randomly selected representative sample of a Spanish population (aged 18-75 y) stratified by age and gender was performed. Plasma and red cell folate, plasma cobalamin, fasting plasma total homocysteine (tHcy) concentration, methylenetetrahydrofolate reductase C677T polymorphism, and FR-autoantibody titer were determined in blood samples from 787 fasting participants. Lifestyle data were collected and milk intake estimated from a 3-d dietary record. FR-autoantibody prevalence was 7.2% [0.30 +/- 0.27 nmol (mean +/- SD) FR blocked/L], equally affecting men and women of all ages. Plasma and red cell folate and tHcy did not differ between carriers and noncarriers of FR-autoantibodies. Milk intake was higher in carriers (225 +/- 199 g/d) than in noncarriers (199 +/- 147 g/d) (P < 0.01). The risk of having FR-autoantibodies increased progressively with increasing quintile of milk intake and was significant in the highest quintile (> or =307 g/d) compared with the lowest (< or =67 g/d) [odds ratio (OR), 2.41 [95% CI: 1.02, 5.69]; P < 0.05; linear trend, P = 0.02]. We concluded that FR-autoantibodies occur in men and women of all ages and do not affect indicators of folate status such as plasma and red cell folate and tHcy. Higher milk intake is associated with increased risk of having FR-autoantibodies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19282368     DOI: 10.3945/jn.108.102475

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  5 in total

1.  Levels of folate receptor autoantibodies in maternal and cord blood and risk of neural tube defects in a Chinese population.

Authors:  Na Yang; Linlin Wang; Richard H Finnell; Zhiwen Li; Lei Jin; Le Zhang; Robert M Cabrera; Rongwei Ye; Aiguo Ren
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2016-05-11

2.  Association between inhibited binding of folic acid to folate receptor alpha in maternal serum and folate-related birth defects in Norway.

Authors:  A L Boyles; J L Ballard; E B Gorman; D R McConnaughey; R M Cabrera; A J Wilcox; R T Lie; R H Finnell
Journal:  Hum Reprod       Date:  2011-05-15       Impact factor: 6.918

3.  Riboflavin status modifies the effects of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) polymorphisms on homocysteine.

Authors:  Carlos J García-Minguillán; Joan D Fernandez-Ballart; Santiago Ceruelo; Lídia Ríos; Olalla Bueno; Maria Isabel Berrocal-Zaragoza; Anne M Molloy; Per M Ueland; Klaus Meyer; Michelle M Murphy
Journal:  Genes Nutr       Date:  2014-10-17       Impact factor: 5.523

4.  Autoantibodies to folate receptor alpha during early pregnancy and risk of oral clefts in Denmark.

Authors:  Camilla Bille; Dorthe Almind Pedersen; Anne-Marie Nybo Andersen; Maria A Mansilla; Jeffrey C Murray; Kaare Christensen; Johnathan L Ballard; Elizabeth B Gorman; Robert M Cabrera; Richard H Finnell
Journal:  Pediatr Res       Date:  2010-03       Impact factor: 3.756

5.  Cerebral folate receptor autoantibodies in autism spectrum disorder.

Authors:  R E Frye; J M Sequeira; E V Quadros; S J James; D A Rossignol
Journal:  Mol Psychiatry       Date:  2012-01-10       Impact factor: 15.992

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.